What Is Vitamin K2 and What Does It Do? Benefits, Harms and Its Relationship With Vitamin D
In this article
Vitamin K2 (Menaquinone): The Biochemical Traffic Officer
Presented in recent years by the supplement market almost as an "essential", vitamin K2 (menaquinone)is a fat-soluble micronutrient playing a key role in calcium metabolism. Its mechanism directing calcium entering the body toward bones and teeth rather than blood vessel walls has earned it the name "biochemical traffic officer". But how much of the popular claims is evidence-based, and how much is marketing exaggeration?
- Division of Roles: Vitamin K1 (phylloquinone) activates clotting factors in the liver, while vitamin K2 (menaquinone) carboxylates, in bones, osteocalcinand, in blood vessels, the protein preventing calcium deposits, Matrix Gla Protein (MGP) to activate them.
- Different Forms (MK-4 vs MK-7): The MK-7 form most commonly used in supplements has a blood half-life of ~72 hours , while animal-derived MK-4 has a half-life of only a few hours.
- Is D3 + K2 Combination Essential?: There is no definitive clinical guideline consensus that every healthy person taking routine vitamin D supplements must take vitamin K2; however, it is biologically reasonable support for those using high-dose vitamin D and calcium.
- The Most Critical Life-Saving Warning: Patients taking vitamin K antagonist blood thinners such as warfarin (Coumadin) must never take K2 supplements without physician approval; they may neutralize the drug's effect and cause fatal clots.
Biological Differences Between K1 and K2
Although both belong to the vitamin K family, their chemical side chains, absorption dynamics and target tissues differ completely. K1 tends to remain in the liver, whereas K2 has greater affinity for peripheral tissues (blood vessels and the skeletal system).
| Characteristic | Vitamin K1 (Phylloquinone) | Vitamin K2 (Menaquinone) |
|---|---|---|
| Main Sources | Dark green leafy vegetables (spinach, cabbage, broccoli) | Fermented foods (natto), hard cheeses, egg yolk, liver |
| Target Organ / Tissue | Primarily liver tissue | Bones, blood vessel walls, cartilage and peripheral organs |
| Biochemical Role | Activation of clotting factors (Factors II, VII, IX, X) | Carboxylation of osteocalcin and Matrix Gla Protein (MGP) |
| Circulating Half-Life | Short (clearance within 1 – 2 hours) | Long (for the MK-7 subtype, ~72 hours) |
| Deficiency Pattern | Acute bleeding, prolonged INR, bruising | Accelerated arterial calcification, bone fracture risk |
Vitamin K2 Forms: What Is the Difference Between MK-4 and MK-7?
Menaquinones (MK) are numbered from MK-4 to MK-13 according to the number of isoprenoid units in their side chains. Two main subforms stand out in supplements and clinical studies:
- MK-4 (Short-Chain): Usually obtained synthetically or from animal tissues. Its biological half-life is very short (cleared from plasma within hours). In Japan, it is licensed for prescription osteoporosis treatment at very high doses such as 3 times daily at 15 mg (total 45 mg/gün — milligrams, not micrograms!).
- MK-7 (Long-Chain): Produced through bacterial fermentation (especially the traditional Japanese fermented soy food natto). Distribution to tissues outside the liver is excellent, and it can remain in circulation for up to 3 days. It therefore provides stable blood concentrations at low daily doses (50 – 180 µg) and is considered standard in daily dietary supplements.
Vitamin D3 and K2 Together: What Is the Calcium Paradox?
One of modern functional medicine's most debated topics is the calcium paradox: bone loss (depletion of bone calcium) occurring simultaneously with calcification (calcium accumulation) in blood vessel walls. Vitamins D and K2 form two links in the chain at this point:
Although the theoretical biochemistry is elegant, evidence-based medical literature presents a more nuanced picture:
- Large meta-analyses have not demonstrated a clinically increased coronary calcification risk in healthy people taking standard physiological doses (800 – 2000 IU daily) of vitamin D even without vitamin K2.
- By contrast, in those taking daily 5.000 – 10.000 IU or higher, very high-dose vitamin D, or older individuals taking additional calcium, adding vitamin K2 (MK-7) provides a reasonable and safe biological barrier.
Which Foods Contain Vitamin K2?
Because vitamin K2 is bacterial in origin, it is almost absent from standard plant-based diets. In Western diets, most K2 comes from fermented dairy products and animal fats.
| Food Source | Average K2 Content (per 100 grams) | Predominant Subtype |
|---|---|---|
| Natto (Japanese fermented soybeans) | 850 – 1000 µg (By far the richest source) | MK-7 |
| Hard/Aged Cheeses (Gouda, Edam, Cheddar) | 40 – 75 µg | MK-8, MK-9 |
| Free-Range Egg Yolk | 25 – 35 µg | MK-4 |
| Butter (Especially from grass-fed animals) | 15 µg | MK-4 |
| Beef / Chicken Liver | 10 – 15 µg | MK-4 |
| Fermented Cabbage (Sauerkraut) | 2 – 5 µg | MK-7 |
What Does Clinical Evidence Say? Summary of Scientific Studies
- The Rotterdam Study (2004): In this landmark cohort of 4.807 participants followed for 7 years, the group with the highest dietary K2 intake had coronary heart disease mortality risk reduced by %57and all-cause mortality reduced by %26 as observed. Interestingly, no association was found between K1 intake and this protective effect.
- 3-Year MK-7 Osteoporosis Study (Knapen et al., 2013): In 244 healthy postmenopausal women, daily 180 µg MK-7 significantly slowed age-related loss of bone mineral density and preserved bone strength indices.
- Cancer Research: Although preclinical studies preventing liver cancer (hepatocellular carcinoma) recurrence and apoptotic effects in leukemia cell lines are promising, K2 has no standard role in cancer treatment.
Safety, Drug Interactions and Who Should Be Careful?
Warfarin and related classic vitamin K antagonist anticoagulants thin the blood by suppressing clotting factor synthesis. Even a tiny amount of supplemental vitamin K2 can overcome this inhibition and cause a rapid fall in INR and the risk of fatal intravascular thrombosis/stroke.
New-generation direct oral anticoagulants (DOACs — rivaroxaban, apixaban, edoxaban, dabigatran) act directly on thrombin or Factor Xa and theoretically do not interact with the vitamin K mechanism. However, these patients should also avoid supplements without consulting a physician.
- Toxicity Threshold: Although vitamin K2 is not water-soluble, it does not accumulate as much as other fat-soluble vitamins (A and D) or cause toxic hypervitaminosis. Even daily doses up to 45 mg (45.000 µg) have not shown liver damage or hypercalcinemia.
- Rare Adverse Effects: Sensitive individuals may experience mild nausea, diarrhea, headache and, rarely, allergic skin rashes.
- Pregnancy and Breastfeeding: The safety during pregnancy of high-dose K2 supplements exceeding daily physiological dietary amounts has not been established.
Usage Guide: What Dose, When and How Should It Be Taken?
- Target Dose Range: For general health and prevention in healthy adults, daily 50 – 100 µg MK-7 is sufficient. In postmenopausal women at osteoporosis risk, clinical studies favor 180 µg/gün as the dose.
- Timing: Vitamin K2 is fat-soluble. For maximum absorption (bioavailability), it must be taken with a main meal containing fat (for example, an olive-oil salad or breakfast with eggs or cheese).
- Choosing a Form: Check the label and prefer naturally fermented MK-7 (Menaquinone-7) for the convenience of once-daily use.
DROZDOGAN ACADEMY COMMENTARY
Vitamin K2 has become one of the supplement industry's most aggressively marketed areas. Although its biochemical rationale makes considerable sense, the distance between clinical evidence and marketing rhetoric must be understood correctly.
⚡ Why Does This Debate Matter?
For decades, traditional medicine taught vitamin K only as a 'clotting' factor. Discovery of K2 revealed its independent regulation of calcium's delicate distribution between tissues (bone versus vessels). This strengthened the hypothesis that atherosclerosis and osteoporosis may be two sides of the same coin.
✅ Facts With Strong Evidence
Epidemiological data (the Rotterdam study, etc.) show substantially less coronary artery calcification in populations with K2-rich diets. It is also biochemically undisputed that MK-7, thanks to its long half-life, effectively increases serum osteocalcin and MGP carboxylation.
⚠️ Exaggerated Claims and Limitations
The supplement industry pursues fear-based sales by creating the impression that "Everyone taking vitamin D will develop calcified arteries without K2" as its message. Yet no randomized clinical trial shows increased heart attack risk in healthy individuals taking daily 1000–2000 IU vitamin D without K2 supplements. Proof that K2 supplementation definitively prevents heart attacks or fractures, from large Phase 3 trials with hard endpoints, is still lacking.
🩺 Our Clinical Approach and Recommendation
Our priority is always a natural diet: include quality aged cheeses, farm eggs and probiotic fermented foods. If you receive high-dose vitamin D treatment or have osteoporosis at an advanced age, adding daily 100 µg MK-7 is a safe, rational approach. However, our patients with heart valve or rhythm conditions who take warfarin must strictly avoid this molecule.
References and Literature
- Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100-3105.
- Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507.
- Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-3283.
- Theuwissen E, Cranenburg EC, Vermeer C. The role of vitamin K in soft-tissue calcification. Adv Nutr. 2012;3(2):166-173.
- Maresz K. Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health. Integr Med (Encinitas). 2015;14(1):34-39.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.